Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management
- PMID:27255100
- PMCID: PMC4891388
- DOI: 10.1007/s11864-016-0403-7
Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management
Abstract
Imaging determines the optimal treatment for rectal cancer patients. High-resolution magnetic resonance imaging (MRI) overcomes many of the known limitations of previous methods. When performed in accordance with the recommended standards, MRI enables accurate staging of both early and advanced rectal cancer, accurate response assessment, the delineation of recurrent disease and planning surgical treatment in a safe and effective manner. Tumour-related high-risk features with known adverse outcomes can be preoperatively identified and treated with neoadjuvant chemoradiotherapy. Further, MRI post-treatment tumour response assessment using TRG grading system also predicts the likely survival outcomes and in the future will be used to modify treatment further by stratification into good and poor responders. There is a paucity of literature with validated outcome data concerning use of diffusion-weighted imaging and positron emission tomography (PET)/computed tomography (CT), and in the absence of any validated methods and outcome data, their use in the initial assessment and restaging after treatment is limited to research protocols. Combination MRI and CT is essential for distant spread assessment and recurrent disease, and currently PET-CT is sometimes used in the workup of patients with recurrent and metastatic disease.
Keywords: CRM; EMVI; ERUS; Early and advanced rectal cancer; High-resolution MRI; N stage; PET/CT; Rectal cancer staging; Recurrent and mucinous rectal cancer; Response assessment; T stage.
Similar articles
- The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.Barbaro B, Leccisotti L, Vecchio FM, Di Matteo M, Serra T, Salsano M, Poscia A, Coco C, Persiani R, Alfieri S, Gambacorta MA, Valentini V, Giordano A, Bonomo L.Barbaro B, et al.Br J Radiol. 2017 Jan;90(1069):20150836. doi: 10.1259/bjr.20150836. Epub 2016 Nov 15.Br J Radiol. 2017.PMID:27845566Free PMC article.
- [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].Wang Y, Chen G.Wang Y, et al.Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jun 25;20(6):630-634.Zhonghua Wei Chang Wai Ke Za Zhi. 2017.PMID:28643307Chinese.
- Multimodal imaging evaluation in staging of rectal cancer.Heo SH, Kim JW, Shin SS, Jeong YY, Kang HK.Heo SH, et al.World J Gastroenterol. 2014 Apr 21;20(15):4244-55. doi: 10.3748/wjg.v20.i15.4244.World J Gastroenterol. 2014.PMID:24764662Free PMC article.Review.
- Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G.Hunter CJ, et al.Ann Surg Oncol. 2012 Apr;19(4):1199-205. doi: 10.1245/s10434-011-2036-1. Epub 2011 Sep 13.Ann Surg Oncol. 2012.PMID:21913017
- Anorectal staging: is EUS necessary?Cesmeli E.Cesmeli E.Minerva Med. 2014 Oct;105(5):423-36. Epub 2014 Jul 7.Minerva Med. 2014.PMID:25000219Review.
Cited by
- Minimally Invasive Endoscopic and Surgical Management of Rectal Neoplasia.Al Ghamdi SS, Leeds I, Fang S, Ngamruengphong S.Al Ghamdi SS, et al.Cancers (Basel). 2022 Feb 14;14(4):948. doi: 10.3390/cancers14040948.Cancers (Basel). 2022.PMID:35205695Free PMC article.Review.
- Clinical feasibility of the therapeutic strategies total neoadjuvant therapy and "watch and wait" in the treatment of rectal cancer patients with recurrence after clinical complete response.Dai D, Liu G, Liu H, Liu Y, Liu X, Li S, Lei Y, Gao Y, Wang Y, Zhang S, Zhang R.Dai D, et al.Front Surg. 2023 Jan 16;9:1006624. doi: 10.3389/fsurg.2022.1006624. eCollection 2022.Front Surg. 2023.PMID:36726944Free PMC article.
- [Evidence-based surgery of rectal cancer].Grade M, Flebbe H, Ghadimi BM.Grade M, et al.Chirurg. 2019 May;90(5):387-397. doi: 10.1007/s00104-019-0802-y.Chirurg. 2019.PMID:30758634Review.German.
- MRI-based nomogram analysis: recognition of anterior peritoneal reflection and its relationship to rectal cancers.Zhang S, Chen F, Ma X, Wang M, Yu G, Shen F, Gao X, Lu J.Zhang S, et al.BMC Med Imaging. 2021 Mar 17;21(1):50. doi: 10.1186/s12880-021-00583-7.BMC Med Imaging. 2021.PMID:33731051Free PMC article.
- Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).van den Berg K, Schaap DP, Voogt ELK, Buffart TE, Verheul HMW, de Groot JWB, Verhoef C, Melenhorst J, Roodhart JML, de Wilt JHW, van Westreenen HL, Aalbers AGJ, van 't Veer M, Marijnen CAM, Vincent J, Simkens LHJ, Peters NAJB, Berbée M, Werter IM, Snaebjornsson P, Peulen HMU, van Lijnschoten IG, Roef MJ, Nieuwenhuijzen GAP, Bloemen JG, Willems JMWE, Creemers GJM, Nederend J, Rutten HJT, Burger JWA.van den Berg K, et al.BMC Cancer. 2022 Sep 6;22(1):957. doi: 10.1186/s12885-022-09947-w.BMC Cancer. 2022.PMID:36068495Free PMC article.
References
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources